The DOI matches its Crossref record; 30 of the 32 references it cites were found in a registry or an index.
Can incorporating molecular testing improve the accuracy of newborn screening for congenital adrenal hyperplasia
Open accessAbstract
Context: Single-tier newborn screening (NBS) for congenital adrenal hyperplasia (CAH) using 17-hydroxyprogesterone (17OHP) measured by fluoroimmunoassay (FIA) in samples collected at 24 to 48 hours produces a high false-positive rate (FPR). Second-tier steroid testing can reduce the FPR and has been widely implemented. Objective: We investigated the accuracy of an alternative multitier CAH NBS protocol that incorporates molecular testing of the CYP21A2 gene and reduces the first-tier 17OHP cutoff to minimize missed cases. Methods: We create a Minnesota-specific CYP21A2 pathogenic variants panel; developed a rapid, high-throughput multiplex, allele-specific-primer-extension assay; and performed a 1-year retrospective analysis of Minnesota NBS results comparing metrics between a conventional steroid-based 2-tier protocol and a molecular-based multitier NBS protocol, applied post hoc. Results: CYP21A2 gene sequencing of 103 Minnesota families resulted in a Minnesota-specific panel of 21 pathogenic variants. The Centers for Disease Control and Prevention created a molecular assay with 100% accuracy and reproducibility. Two-tier steroid-based screening of 68 659 live births during 2015 resulted in 2 false negatives (FNs), 91 FPs, and 1 true positive (TP). A 3-tier protocol with a lower first-tier steroid cutoff, second-tier 21-variant CYP21A2 panel, and third-tier CYP21A2 sequencing would have resulted in 0 FNs, 52 FPs, and 3 TPs. Conclusion: Incorporation of molecular testing could improve the accuracy of CAH NBS, although some distinct challenges of molecular testing may need to be considered before implementation by NBS programs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Population-based studies demonstrate that molecular integration enhances sensitivity, reduces false positives by up to 32%, and facilitates lowering 17-OHP cutoffs without compromising specificity, benefits unattainable with biochemical approaches alone (98).”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [98]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conversion of maternal cortisol to cortisone during placental transfer to the human fetus
Murphy, B. E. P., Clark, S. J., Donald, I. R., Pinsky, M., & Vedady, D. (1974) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)33697-3 · Cited by 240
Glucocorticoid Sensitivity Is Determined by a Specific Glucocorticoid Receptor Haplotype
Stevens, A., Ray, D. W., Zeggini, E., John, S., Richards, H. L., Griffiths, C. E. M., & Donn, R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031235 · Cited by 177
Developmental origins of the human hypothalamic-pituitary-adrenal axis
Howland, M. A., Sandman, C. A., & Glynn, L. M. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1356222 · Cited by 168
Wong, T., Shackleton, C. H., Covey, T. R., & Ellis, G. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1830 · Cited by 159
Mechanisms for establishment of the placental glucocorticoid barrier, a guard for life
Zhu, P., Wang, W., Zuo, R.-J., & Sun, K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2918-5 · Cited by 128
CYP21A2 mutation update: Comprehensive analysis of databases and published genetic variants
Simonetti, L., Bruque, C. D., Fernández, C. S., Benavides-Mori, B., Delea, M., Kolomenski, J. E., Espeche, L. D., Buzzalino, N. D., Nadra, A. D., & Dain, L. (2018) · Human Mutation · doi:10.1002/humu.23351 · Cited by 122
Gidlöf, S., Wedell, A., Guthenberg, C., von Döbeln, U., & Nordenström, A. (2014) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2013.5321 · Cited by 119
Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
Held, P. K., Bird, I. M., & Heather, N. L. (2020) · International Journal of Neonatal Screening · doi:10.3390/ijns6030067 · Cited by 79
Doerr, H. G., Sippell, W. G., VERSMOLD, H. T., BIDLINGMAIER, F., & Knorr, D. (1988) · Pediatric Research · doi:10.1203/00006450-198805000-00018 · Cited by 70
Maturity of the Adrenal Cortex in Very Preterm Infants Is Related to Gestational Age
Bolt, R. J., van Weissenbruch, M. M., Popp‐Snijders, C., Sweep, F. C. G. J., Lafeber, H. N., & de Waal, H. A. D. (2002) · Pediatric Research · doi:10.1203/00006450-200209000-00017 · Cited by 69
Cited by
Güran, T., Yuruker, E., Anık, A., Atar, M., Çamtosun, E., Eviz, E., İsakoca, M., Mengen, E., Tosun, B. G., Turan, İ., et al. (2025) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2025.2024-9-11 · Cited by 5
Ladjouze, A., Ouarezki, Y., Djermane, A., Kherra, S., Meriem, B., Mohammedi, K., Douiri, D., Boutaghane, N., Bouzerar, Z., & Vliet, G. V. (2025) · Hormone Research in Paediatrics · doi:10.1159/000543430 · Cited by 3
Miranda, M. C. D., Oliveira, A. C. M. D., Soares, G. J., Batatinha, J. A. P., Latronico, A. C., Mendonca, B. B., & Bachega, T. A. S. S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1770274 · Cited by 2
Carvalho, D. F., Lima‐Valassi, H. P., Hayashi, G. Y., Oliveira, A. C. M., Matias, G. D. S. S., Alves, A. N. L., de Miranda, M. C., Funari, M. F. A., Madureira, G., Latronico, A. C., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag107 · Cited by 2
Grosse, S. D. (2025) · Jornal de Pediatria · doi:10.1016/j.jped.2025.02.001 · Cited by 1
Self-citation
Metadata
- Authors
- Sarafoglou, K., Gaviglio, A., Wolf, C., Lorentz, C. P., Lteif, A., Kyllo, J., Radloff, G., Detwiler, Z., Cuthbert, C. D., Hodges, J. S., Grosse, S. D., Greene, C. N., & Cordovado, S.
- Affiliations
- University of Minnesota (US)
- Minnesota Department of Health (US)
- Mayo Clinic (US)
- Children’s Minnesota - St. Paul Hospital (US)
- Centers for Disease Control and Prevention (US)
- Corresponding author
- Sarafoglou, Kyriakie
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2024-05-03
- Volume
- 110
- Issue
- 4
- Pages
- e1194-e1203
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC11531606
- OpenAlex
- W4396605079
- Cited by
- 8
- References
- 32
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 1
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- March of Dimes (6-FY14-440)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, newborn screening, CYP21A2 gene, molecular testing, 17-hydroxyprogesterone, false positive rate
- MeSH terms
- Adrenal Hyperplasia, Congenital, False Positive Reactions, Female, Genetic Testing, Humans, Infant, Newborn, Male, Minnesota, Retrospective Studies, Steroid 21-Hydroxylase, Fluoroimmunoassay, Reproducibility of Results, Neonatal Screening, 17-alpha-Hydroxyprogesterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Can incorporating molecular testing improve the accuracy of newborn screening for congenital adrenal hyperplasia. https://app.cochat.ai/papers/10.1210/clinem/dgae297
- The paper
- Sarafoglou, K., Gaviglio, A., Wolf, C., Lorentz, C. P., Lteif, A., Kyllo, J., Radloff, G., Detwiler, Z., Cuthbert, C. D., Hodges, J. S., Grosse, S. D., Greene, C. N., & Cordovado, S. (2025). Can incorporating molecular testing improve the accuracy of newborn screening for congenital adrenal hyperplasia. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae297
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.